US Capitol Capsule: Cancer Therapies, Orphan Drugs Dominated 2015 Approvals; PCSK9s Arrived
This article was originally published in Scrip
Executive Summary
Cancer therapies dominated US drug approvals in 2015, with the FDA's Center for Drug Evaluation and Research (CDER) also giving its nod to a record number of medicines that had gained orphan drug designation.